Porter, D L; Antin, J H (1998) Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia. Hematol Oncol Clin North Am 12:123-50
|
Porter, D L; Antin, J H (1997) Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions. Cancer Treat Res 77:57-85
|
Ballen, K K; Gilliland, D G; Guinan, E C et al. (1997) Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia. Bone Marrow Transplant 20:737-43
|
Lee, S J; Wegner, S A; McGarigle, C J et al. (1997) Treatment of chronic graft-versus-host disease with clofazimine. Blood 89:2298-302
|
Benjamin, R J; Linsley, L; Fountain, D et al. (1997) Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion 37:79-85
|
Porter, D L; Roth, M S; Lee, S J et al. (1996) Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation. Bone Marrow Transplant 18:975-80
|
Mitus, A J; Miller, K B; Schenkein, D P et al. (1995) Improved survival for patients with acute myelogenous leukemia. J Clin Oncol 13:560-9
|
Porter, D L; Antin, J H (1995) Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation. Leuk Lymphoma 17:191-7
|
Benjamin, R J; Linsley, L; Axelrod, J D et al. (1995) The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support. Transfusion 35:837-44
|
Antin, J H (1994) Cytokines and graft-V-host disease. Prog Clin Biol Res 390:193-202
|
Showing the most recent 10 out of 14 publications